Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP564246.RATR3LEIUExf7c0-TnSVs-H3HMQeN5z5nXnTaKyH7nqs0130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564246.RATR3LEIUExf7c0-TnSVs-H3HMQeN5z5nXnTaKyH7nqs0130_provenance.
• NP453047.RADfUPD8TcMwZkzxE31A-03CTt9NuqWvGOrHqCIaXx-jE130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453047.RADfUPD8TcMwZkzxE31A-03CTt9NuqWvGOrHqCIaXx-jE130_provenance.
• NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380321.RARu_gJOqDnM5PSkGqXX71Tq56xeeCBGNJAXl02k6XG8E130_provenance.
• NP884706.RAsCHX2eY6By-oiXMOSAVxOaygS68_QNh6hw26qActAkg130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP884706.RAsCHX2eY6By-oiXMOSAVxOaygS68_QNh6hw26qActAkg130_provenance.
• NP754255.RAhf6nGXHYCDXchSMU0q6celyrRca3YHwwKHQ_inNctKc130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754255.RAhf6nGXHYCDXchSMU0q6celyrRca3YHwwKHQ_inNctKc130_provenance.
• NP379476.RAX2ut4_cNUhaeLXuLN0WG5P7SUAf0GBueUTwi21o4p0c130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379476.RAX2ut4_cNUhaeLXuLN0WG5P7SUAf0GBueUTwi21o4p0c130_provenance.
• NP527548.RAy5TXAyC6dEQYBZyjNz6R7geqgZJCDzqCZO-so7tZoeU130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527548.RAy5TXAyC6dEQYBZyjNz6R7geqgZJCDzqCZO-so7tZoeU130_provenance.
• assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP752158.RAxuI_htrjfUC3J63Esx2J3ssLrY79rm7Mo3FlJX796ZI130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752158.RAxuI_htrjfUC3J63Esx2J3ssLrY79rm7Mo3FlJX796ZI130_provenance.
• assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP765300.RAxvVNJVCDvg3DyPaBNJKImJl_6VHSZuUcPPyBKf3ptBE130_provenance.
• NP765305.RA52BBBcLK-XjiHLfwXNUsN0gtCMWxjb34kA9pX_onRY8130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP765305.RA52BBBcLK-XjiHLfwXNUsN0gtCMWxjb34kA9pX_onRY8130_provenance.
• assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP527624.RAK7kuH27ZgmhdsGIVrw1yLJdAL-KzKShKIERBt6xk3Vo130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527624.RAK7kuH27ZgmhdsGIVrw1yLJdAL-KzKShKIERBt6xk3Vo130_provenance.
• NP765302.RAZXem3a53anCtSMNdwNcxdoIh9i-4EhaO2hdnzizZzsU130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP765302.RAZXem3a53anCtSMNdwNcxdoIh9i-4EhaO2hdnzizZzsU130_provenance.
• NP765303.RASaIm4luVboExUIdyIk9V8aezOEIuLYr2zSYJRgNl5pQ130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP765303.RASaIm4luVboExUIdyIk9V8aezOEIuLYr2zSYJRgNl5pQ130_provenance.
• NP765304.RAfSmbjHgHKXfyPmsOReUH3juDVSoO5xLCZcrRM4kBjCs130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP765304.RAfSmbjHgHKXfyPmsOReUH3juDVSoO5xLCZcrRM4kBjCs130_provenance.
• NP751696.RAPdbgmR2-MthGSC1PkCZMHnKlmfkcRO2jSA_aVYEQHuA130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751696.RAPdbgmR2-MthGSC1PkCZMHnKlmfkcRO2jSA_aVYEQHuA130_provenance.
• assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP379323.RAklVtd6hlQze1xpSRaUDEfr6hKwTeuridqRfp7aIRDa0130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379323.RAklVtd6hlQze1xpSRaUDEfr6hKwTeuridqRfp7aIRDa0130_provenance.
• NP765301.RAG956LYj1HVJ6PNdNMgCWWE-VQUxXp406JbNxSc243cc130_assertion description "[Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP765301.RAG956LYj1HVJ6PNdNMgCWWE-VQUxXp406JbNxSc243cc130_provenance.